Medication

Beyfortus® (Nirsevimab-alip)

A one-page care plan for patients taking Beyfortus® (Nirsevimab-alip), covering Prevention & Protection, Expectations & Execution, Nutrition & Next Steps, Consistency, Indications and Lifestyle & Long-Term Success.

In this plan

  1. Prevention & Protection

    • I know Beyfortus is an RSV antibody, not a vaccine. It lowers the risk of severe RSV lung disease.
    • I know a dose helps protect my child for about 5 months. It does not treat an RSV infection.
    • I ask about a first-season dose before age 8 months if the mother's RSV shot in pregnancy is missing, unknown, or less than 14 days before birth.
    • I know most babies do not need both if the mother's shot was at least 14 days before birth. I ask about exceptions.

  2. Expectations & Execution

    4 points, for partners

  3. Nutrition & Next Steps

    4 points, for partners

  4. Consistency

    4 points, for partners

  5. Indications

    4 points, for partners

  6. Lifestyle & Long-Term Success

    4 points, for partners

When to call the office and when to call 911: for partners

See the full plan

Beyfortus® (Nirsevimab-alip) is one of the plans included with a partnership. Partners read every plan in full, and print any of them for a patient.

Become a partner to save & printLog in
© 2026 PENCIL Health